[Prognosis, prophylaxis, and early therapy of fetoplacental insufficiency].
Parameters characterizing the bloodflow, system of hemostasis, were determined together with the level of the key hormones (estriol and placental lactogen) in 70 pregnant women running a risk for development of placental insufficiency as well as in those pregnant women presenting with clinical manifestations of placental insufficiency at week 6 to 40. The parameters have been noted to get worse during the period of placentation. Augmentation of resistance of the uterine arteries and umbilical artery, ultrasonic signs, decline in the hormonal activity of the placental complex, changes in the hemostasiogram--all these events come to be seen before the appearance of the first clinical signs of placental insufficiency. The studied parameters have been shown to get improved by early complex treatments of administration.
Kramarenko
O P
OP
D000328:Adult; D004964:Estriol / Q000097:blood; D005260:Female; D006487:Hemostasis; D006801:Humans; D010920:Placenta / Q000098:blood supply / Q000502:physiology / Q000503:physiopathology; D010927:Placental Insufficiency / Q000503:physiopathology / Q000517:prevention & control / Q000628:therapy; D010928:Placental Lactogen / Q000097:blood; D011247:Pregnancy; D011264:Pregnancy Trimesters; D011379:Prognosis
D010928:Placental Lactogen; D004964:Estriol
Prohnozuvannia, profilaktyka ta rannia terapiia fetoplatsentarnoï nedostatnosti.